Images in Clinical RheumatologyGeneralized Skin Hyperpigmentation and Longitudinal Melanonychia Secondary to Treatment With Hydroxychloroquine in Systemic Lupus ErythematosusHiperpigmentación cutánea generalizada y melanoniquia longitudinal secundarias al tratamiento con hidroxicloroquina en lupus eritematoso sistémico☆
Section snippets
Protection of Persons and Animals
The authors state that no experiments were performed on humans or animals for this study.
Data Confidentiality
The authors state that all of their workplace protocols on the publication of patient data have been followed and that the patients included have received enough information and have given written informed consent to participate in the study.
Right to Privacy and Informed Consent
The authors state that they have obtained the informed consent of the patients and/or subjects referred to in the article. This document is in possession of the
Conflict of Interest
The authors declare no conflict of interests.
References (10)
- et al.
The ISN/RPS 2003 classification of lupus nephritis: an assessment at 3 years
Kidney Int
(2007) - et al.
Hiperpigmentación generalizada. A propósito de un caso
Rev Méd Electrón [online]
(2013) - et al.
A long-term study of hydroxychloroquine withdrawal on exacerbations in systemic lupus erythematosus. The Canadian Hydroxychloroquine Study Group
Lupus
(1998) - et al.
Antipalúdicos
- et al.
Cutaneous hyperpigmentation during therapy with hydroxychloroquine
J Clin Rheumatol
(2007)
Cited by (0)
- ☆
Please cite this article as: Sifuentes Giraldo WA, Grandal Platero M, de la Puente Bujidos C, Gámir Gámir ML. Hiperpigmentación cutánea generalizada y melanoniquia longitudinal secundarias al tratamiento con hidroxicloroquina en lupus eritematoso sistémico. Reumatol Clin. 2013;9:381–2.